Concord Wealth Partners’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2
Closed -$8 1024
2024
Q2
$8 Buy
+2
New +$9 ﹤0.01% 835

Other funds holding TSVT

Concord Wealth Partners's TSVT Position: Q3 2024 in Review

Concord Wealth Partners sold out of 2seventy bio (TSVT) in Q3 2024, closing a stake of 2 shares — an estimated $8 sold.

Concord Wealth Partners first reported a position in TSVT in Q2 2024 and held it in 1 quarter. The position peaked at $8 in Q2 2024. 115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.

  • Concord Wealth Partners reported no remaining 2seventy bio position as of Q3 2024 after selling out during the quarter.
  • Concord Wealth Partners sold 2 2seventy bio shares in Q3 2024, an estimated $8.
  • Concord Wealth Partners first reported a position in 2seventy bio in Q2 2024 and held it in 1 quarter.
  • Concord Wealth Partners's 2seventy bio position peaked at $8 in Q2 2024.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.

Based on Concord Wealth Partners's 13F filing for Q3 2024, filed 24 Oct 2024.